case_images: PMC10314751_01
case_images: Lesion before treatment (A-C). Notice the thickness of the lesion is 1 cm (D).
case_images: CCID-16-1659-g0001.jpg
case_images: PMC10314751_01_CCID-16-1659-g0001.jpg
case_images: f0001
case_images: During the physical examination, we observed several keloidal lesions on both the left and right scapula, with the largest lesion measured 8.5 x 5.5 x 1 cm (Figure 1).
case_images: Spring-powered NFI device. Injector body (A). Nozzle (B) drug delivery disposable sterile medication cartridge. Reset box (C) for charging the injector. Adapter (D) for filling nozzle from vial.
case_images: CCID-16-1659-g0002.jpg
case_images: PMC10314751_01_CCID-16-1659-g0002.jpg
case_images: f0002
case_images: TA (40 mg/mL) and 5-FU (50 mg/mL) intralesional injection using NFI (Thesera ) at a dose of 0.1 mL/cm2 (Figure 2).
case_images: Lesion after 4 sessions (A-C). The thickness had been decreased to 0.5 cm (D).
case_images: CCID-16-1659-g0003.jpg
case_images: PMC10314751_01_CCID-16-1659-g0003.jpg
case_images: f0003
case_images: Throughout this time, there was a noticeable improvement in the lesion, as it began to flatten for 0.5 cm (Figure 3).